Chile - español - ISPC (Instituto de Salud Pública de Chile)

laboratorio bagÓ de chile s.a. - simoctocog alfa - simoctocog alfa (factor viii de coagulacion humano recombinante) 500 ui - tratamiento y profilaxis del sangrado en pacientes con hemofilia a (deficiencia congénita de factor viii). nuwiq puede ser utilizado en todos los grupos de edad

Chile - español - ISPC (Instituto de Salud Pública de Chile)

laboratorios wyeth llc. - venlafaxina - sin formulas

Chile - español - ISPC (Instituto de Salud Pública de Chile)

laboratorio bagÓ de chile s.a. - simoctocog alfa - sin formulas

Chile - español - ISPC (Instituto de Salud Pública de Chile)

laboratorio bagÓ de chile s.a. - simoctocog alfa - sin formulas

Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

hanai s.r.l. - droguerÍa - solucion para perfusion - por mililitro 100.00 ml - - aminoácidos y derivados

Unión Europea - español - EMA (European Medicines Agency)

sun pharmaceutical industries (europe) b.v. - ertapenem sodio - infecciones bacterianas - ertapenem - treatmentertapenem sun is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4. 4 y 5. 1):- intra-abdominal infections- community acquired pneumonia- acute gynaecological infections- diabetic foot infections of the skin and soft tissue (see section 4. 4)preventionertapenem sun is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4. se debe dar consideración a las directrices oficiales sobre el uso adecuado de agentes antibacterianos.

Unión Europea - español - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - teriparatida - osteoporosis; osteoporosis, postmenopausal - homeostasis del calcio - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

medior healthcare pvt ltd india - alprostadil????????? 500 mcg - solucion para inyeccion - cada ml contiene: alprostadil????????? 500 mcg

Unión Europea - español - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.